Kerry Chester
Institute of Cancer Research(GB)Newcastle upon Tyne Hospitals NHS Foundation Trust(GB)Freeman Hospital(GB)London Cancer(GB)Recombinant Antibody Technology (United Kingdom)(GB)CRUK Lung Cancer Centre of Excellence(GB)University College London(GB)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Glycosylation and Glycoproteins Research, Radiopharmaceutical Chemistry and Applications, Health, Medicine and Society
Most-Cited Works
- → Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors(2017)425 cited
- → The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity(2017)403 cited
- → Stromal features are predictive of disease mortality in oral cancer patients(2010)337 cited
- → The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors(2005)305 cited
- → Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library(1996)242 cited
- → A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy(2015)239 cited